We now extend these studies to show that integrin α7 protein expression is significantly increased in patients with severe asthma and that integrin α7β1 blockade not only reduces contractile ASM phenotype (ie. reduction in sm-α-actin) but also prevents their conversion back to a proliferative phenotype via a Kras-dependent mechanism. The gene discussed is KRAS; the disease is asthma.